Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorNational Cancer Center, Korea
About this trial
\[Study objectives\] To evaluate the efficacy and safety of the combined treatment of radiotherapy and endoscopic intraductal radiofrequency ablation in patients with locoregional extrahepatic cholangiocarcinoma.
Eligibility criteria
Qualifiers
Patients 20 years of age or older, who voluntarily agree to participate in the study and sign the informed consent.
Patients with cytopathologically diagnosed inoperable extrahepatic cholangiocarcinoma
Disqualifiers
Patients who refuse to sign the informed consent
Patients with metastatic cancer (stage IV) or malignant ascites
Patients with intrahepatic cholangiocarcinoma
Patients who are unable to undergo endoscopic procedures as determined by the investigator.
Trial design
Treatments tested in this trial
- ID-RFA and Radiotherapy
Treatment groups
53 Participants
are divided into 1 treatment groupSponsors and collaborators
National Cancer Center, Korea
Lead sponsor
Boston Scientific Corporation
Collaborator
Source ClinicalTrials.gov